Insider Transactions in Q4 2022 at Veracyte, Inc. (VCYT)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2022
|
Evan/ Fa Jones Director |
SELL
Open market or private sale
|
Direct |
600
-1.18%
|
$18,000
$30.13 P/Share
|
|
Dec 13
2022
|
Evan/ Fa Jones Director |
SELL
Open market or private sale
|
Direct |
1,667
-1.6%
|
$51,677
$31.08 P/Share
|
|
Dec 06
2022
|
Giulia C Kennedy Chief Scientific & Med Officer |
SELL
Open market or private sale
|
Direct |
1,023
-1.53%
|
$27,621
$27.03 P/Share
|
|
Dec 02
2022
|
Bonnie H Anderson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,042
-3.14%
|
$59,218
$29.14 P/Share
|
|
Dec 02
2022
|
Marc Stapley Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,012
-0.64%
|
$29,348
$29.14 P/Share
|
|
Dec 02
2022
|
Rebecca Chambers Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
735
-1.0%
|
$21,315
$29.14 P/Share
|
|
Dec 02
2022
|
Giulia C Kennedy Chief Scientific & Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,008
-1.48%
|
$29,232
$29.14 P/Share
|
|
Dec 01
2022
|
Bonnie H Anderson Director |
SELL
Open market or private sale
|
Direct |
80,000
-32.49%
|
$2,240,000
$28.21 P/Share
|
|
Dec 01
2022
|
Bonnie H Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
80,000
+23.72%
|
$720,000
$9.98 P/Share
|
|
Nov 11
2022
|
Giulia C Kennedy Chief Scientific & Med Officer |
SELL
Open market or private sale
|
Direct |
2
-0.0%
|
$58
$29.34 P/Share
|
|
Nov 11
2022
|
Giulia C Kennedy Chief Scientific & Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2
+0.0%
|
$28
$14.34 P/Share
|
|
Nov 11
2022
|
Evan/ Fa Jones Director |
SELL
Open market or private sale
|
Direct |
6,000
-5.14%
|
$180,000
$30.62 P/Share
|
|
Nov 04
2022
|
Giulia C Kennedy Chief Scientific & Med Officer |
SELL
Open market or private sale
|
Direct |
1,023
-1.48%
|
$25,575
$25.0 P/Share
|
|
Oct 13
2022
|
Bonnie H Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,088
+6.76%
|
$88,704
$8.96 P/Share
|